Search Results - "Koloskova, N. N."

The role of frailty in selecting patients for heart transplantation by N. N. Koloskova, A. O. Shevchenko

“…The role of frailty in cardiovascular disease is becoming increasingly recognized. Up to 79% of patients with heart failure are frail. Frailty is associated…”
Get full text

Heart transplantation for primary cardiac sarcoma by A. Yu. Goncharova, N. N. Koloskova, V. N. Poptsov, V. M. Zakharevich, N. P. Mojeiko, А. R. Zakiryanov, N. N. Sayfullina, K. S. Kiryakov, S. V. Gautier

“…Primary cardiac sarcoma is a rapidly progressive, aggressive cardiac tumor that is very rare in the general population. Conservative treatment for this tumor…”
Get full text

Сlinical features of malignant tumors against the background of immunosuppressive therapy in heart transplant recipients by L. B. Krougly, N. N. Koloskova, A. V. Nikulin, I. V. Pashkov, V. N. Poptsov, A. O. Shevchenko

“…As the survival rate of cardiac recipients improves, higher incidence of malignancy in the late postoperative period becomes essential for their prognosis…”
Get full text

Perioperative period in heart transplantation with extremely prolonged ischemic times (>6 hours) by V. N. Poptsov, V. M. Zakharevich, E. A. Spirina, N. N. Koloskova, V. V. Pchelnikov, V. M. Khatutskii, A. I. Skokova, A. V. Fomichev, E. Z. Aliev, V. A. Boronova, A. V. Bereznyak, A. K. Solodovnikova

“…Amidst the shortage in viable donor hearts, the use of hearts from expanded criteria donors, including those with prolonged ischemic time, remains one of the…”
Get full text

Antibody-mediated rejection in heart transplantation by V. S. Kvan, N. N. Koloskova, Yu. A. Kachanova, N. N. Sayfullina, A. Yu. Goncharova, L. B. Krugly, A. O. Shevchenko

“…The role of antibody-mediated rejection in predicting survival among heart recipients has been studied in clinical transplantology for over 20 years. This…”
Get full text

Intravascular visualization methods in estimating vasculopathy of a transplanted heart by S. A. Sakhovsky, N. N. Koloskova, A. Yu. Goncharova, B. L. Mironkov

“…One of the pathognomonic signs of сardiac allograft vasculopathy is concentric intimal hyperplasia, which can be assessed by intravascular imaging techniques…”
Get full text

SUCCESSFUL HEART TRANSPLANTATION IN PATIENT WITH CRITICAL MULTIORGAN FAILURE by L. A. Bockeria, K. V. Shatalov, N. N. Koloskova, M. B. Yarustovskii, G. V. Lobacheva, M. V. Abramian, V. Yu. Merzliakov, M. M. Rybka, S. L. Gordeev, Yu. A. Nekhai, A. A. Starovoitov, E. A. Trofimova, N. N. Samsonova, M. G. Pliusch, A. G. Zaharchenko, T. B. Averina, Yu. V. Gusarova, I. V. Arnautova, R. R. Ahtiamov

“…Case of successful heart transplantation in patient with dilated cardiomyopathy, which lead to dramatic improvement of his clinical status and physical…”
Get full text

Heart transplantation in diabetic recipients by V. N. Poptsov, E. A. Spirina, E. N. Zolotova, V. M. Zakharevich, N. N. Koloskova, N. P. Mozheiko, A. A. Sibiakina, I. L. Poz, A. I. Skokova, V. V. Boronova, V. Yu. Voronkov, V. M. Khatutskii

“…Introduction. Heart transplantation (HT) in patients with preexisting type 2 diabetes (T2D) is associated with high risk of infectious and non-infectious…”
Get full text

Amiodarone in cardiac transplant waiting list patients with severe heart failure by N. N. Koloskova, V. N. Poptsov, G. M. Salikhova

“…Heart transplantation is the «gold standard» of severe heart failure treatment. Sudden arrhythmic death is the leading cause of death among these patients…”
Get full text

THE INDIVIDUAL TAILORING OF IMMUNOSUPPRESSIVE THERAPY AFTER HEART TRANSPLANTATION by N. N. Koloskova, V. N. Poptsov, A. О. Shevchenko

“…Heart transplantation is the «gold standard» of treatment severe heart failure. Immunosuppressive therapy aimed at the prevention of acute allograft rejection…”
Get full text

Life expectancy of heart recipients with donor-transmitted coronary atherosclerosis by S. A. Sakhovsky, N. N. Koloskova, D. A. Izotov, E. A. Spirina, A. Yu. Goncharova, V. M. Luchkin, B. L. Mironkov

“…Introduction. Heart transplantation (HT) is an extreme treatment for chronic congestive heart failure. One of the ways of reducing deficit of donor organs was…”
Get full text

Controlled arterial hypertension and adverse event free survival rate in heart recipients by Shevchenko, A. О., Nikitina, E. A., Koloskova, N. N., Shevchenko, О. P., Gotje, S. V.

“…Aim. To evaluate the prevalence of arterial hypertension (AH) in heart transplant recipients, and its influence on the risk of adverse events, as the efficacy…”
Get full text

EFFICACY OF MYOCARDIAL REVASCULARIZATION IN POTENTIAL RECIPIENTS OF HEART WITH THE CHRONIC ISCHEMIC HEART FAILURE by S. V. Gautier, A. B. Mironkov, S. A. Sakhovsky, N. N. Koloskova, I. I. Muminov, E. A. Spirina, I. Yu. Tunyaeva, B. L. Mironkov

“…Aim: to evaluate clinical effi ciency of percutaneous coronary interventions (PCI) at potential recipients of heart with the chronic ischemic heart failure…”
Get full text

Prevalence and predictors of hypertension in cardiac recipients by A. O. Shevchenko, E. A. Nikitina, N. P. Mozheiko, I. Yu. Tyunyaeva, N. N. Koloskova

“…Aim. The study was aimed to assess the prevalence and risk factors of hypertension in cardiac recipients.Materials and methods. End-stage heart failure…”
Get full text

The effects of angiotensin-converting enzyme inhibitors in heart recipients: a single center experience by А. О. Shevchenko, R. A. Faradzhov, D. A. Izotov, N. N. Koloskova, Е. A. Nikitina, O. E. Gichkun, V. I. Orlov, I. Yu. Tunyaeva, B. L. Mironkov

“…Aim. To study the effect of ACE inhibitors (ACEI) in heart recipients on the prognosis and myocardial remodeling.Materials and methods. Three hundred and…”
Get full text

Angiographic assessment of coronary arteries atherosclerosis of the heart transplant by S. A. Sakhovsky, D. A. Izotov, N. N. Koloskova, I. I. Muminov, R. L. Ahmadzaj, R. A. Faradzhov, E. A. Spirina, V. N. Poptsov, B. L. Mironkov, A. O. Shevchenko

“…Aim. To estimate the frequency and expressiveness of atherosclerotic lesions of the transplant coronary arteries of the determined by an angiographic…”
Get full text

COVID-19 in solid organ transplant recipients: initial report from national multicenter observational study «ROKKOR-recipient by S. V. Gautier, A. O. Shevchenko, O. M. Tsirulnikova, S. M. Khomyakov, O. N. Kotenko, V. E. Vinogradov, I. N. Abyzov, G. D. Avetisyan, A. Yu. Anisimov, L. Yu. Artyukhina, M. T. Bekov, V. A. Berdinsky, V. S. Bogdanov, A. Yu. Bykov, A. Yu. Vinokurov, A. Yu. Goncharova, D. P. Evdokimov, D. V. Ezersky, V. E. Zagainov, V. M. Zakharevich, K. N. Zelenin, E. S. Ivanova, A. A. Kartashev, N. G. Kvadratova, I. G. Kim, N. N. Koloskova, V. L. Korobka, I. R. Kurbanuglov, M. A. Lysenko, I. A. Miloserdov, Ya. G. Moisyuk, G. V. Nikolaev, I. V. Ostrovskaya, N. Yu. Petrova, A. V. Petryaev, A. V. Pinchuk, V. S. Platonov, V. N. Poptsov, Z. A. Porchkhidze, D. A. Saydulaev, A. D. Sapozhnikov, S. B. Semchenko, M. M. Skorobogatov, V. Yu. Tereshchenko, N. F. Frolova, D. V. Khalikova, T. A. Khalilulin

“…We herein present our initial report from «ROKKOR-recipient», a national multicenter observational study. The prevalence, risk factors, clinical manifestations…”
Get full text

Gender aspects of incidence of antibody-mediated rejection and allograft vasculopathy events after heart transplantation by N. N. Koloskova, V. N. Poptsov, V. М. Zakharevich, I. I. Muminov, N. P. Mozheyko, O. E. Gichkun, Е. А. Nikitina, V. S. Cvan, T. A. Khalilulin, A. R. Zakiryanov, A. O. Shevchenko

“…Despite improvements in immunosuppressive therapy, antibody-mediated rejection (AMR) remains one of the most important risk factors for poor prognosis for…”
Get full text

Heart transplantation waiting list of V.I. Shumakov National Medical Research Center of Transplantology and Artificial Organs. Trends from 2010 to 2017 by S. V. Gautier, V. N. Poptsov, N. N. Koloskova, V. M. Zakharevich, A. О. Shevchenko, I. I. Muminov, E. A. Nikitina, V. S. Kvan, T. A. Halilulin, А. R. Zakiryanov, А. М. Golts

“…The aim: to analyze the waiting list for heart transplantation from 2010 to 2017 and to characterize recipients with chronic heart failure III–IV NYHA…”
Get full text

Conversion to everolimus to preserve kidney function in a heart transplant recipient, a personalized approach of immunos uppressive therapy by N. N. Koloskova, E. A. Nikitina, V. M. Zakharevich, I. I. Muminov, V. S. Cvan, V. N. Poptsov, R. L. Ahmadzai, D. A. Izotov, A. O. Shevchenko

“…Heart transplantation is the «gold standard» of treatment severe heart failure. Patient survival after heart transplantation has improved dramatically since…”
Get full text